DUAL-ACTING BENZOIMIDAZOLE ANTIHYPERTENSIVE AGENTS

The invention is directed to compounds having the formula: wherein: Ar, r, n, X, R2-3 and R5-7 are as defined in the specification, and pharmaceutically acceptable salts thereof. These compounds have AT1 receptor antagonist activity and neprilysin inhibition activity. The invention is also directed...

Full description

Saved in:
Bibliographic Details
Main Authors HUDSON, RYAN, CHOI, SEOK-KI, GENDRON, ROLAND, MCMURTRIE, DARREN, FATHEREE, PAUL, R, MCKINNELL, ROBERT, MURRAY, JENDZA, KEITH, ALLEGRETTI, PAUL, OLSON, BROOKE
Format Patent
LanguageEnglish
French
German
Published 17.03.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention is directed to compounds having the formula: wherein: Ar, r, n, X, R2-3 and R5-7 are as defined in the specification, and pharmaceutically acceptable salts thereof. These compounds have AT1 receptor antagonist activity and neprilysin inhibition activity. The invention is also directed to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
AbstractList The invention is directed to compounds having the formula: wherein: Ar, r, n, X, R2-3 and R5-7 are as defined in the specification, and pharmaceutically acceptable salts thereof. These compounds have AT1 receptor antagonist activity and neprilysin inhibition activity. The invention is also directed to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
Author GENDRON, ROLAND
MCMURTRIE, DARREN
CHOI, SEOK-KI
HUDSON, RYAN
OLSON, BROOKE
JENDZA, KEITH
FATHEREE, PAUL, R
ALLEGRETTI, PAUL
MCKINNELL, ROBERT, MURRAY
Author_xml – fullname: HUDSON, RYAN
– fullname: CHOI, SEOK-KI
– fullname: GENDRON, ROLAND
– fullname: MCMURTRIE, DARREN
– fullname: FATHEREE, PAUL, R
– fullname: MCKINNELL, ROBERT, MURRAY
– fullname: JENDZA, KEITH
– fullname: ALLEGRETTI, PAUL
– fullname: OLSON, BROOKE
BookMark eNrjYmDJy89L5WQwcgl19NF1dA7x9HNXcHL1i_L39PV0cYzy93FVcPQL8fSIDHANCnH1C_YMAwq4u_qFBPMwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknjXACNDMyMTEyNHQ2MilAAASwYogg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate DOPPELTWIRKENDE BLUTDRUCKSENKENDE BENZOIMIDAZOLMITTEL
AGENTS ANTIHYPERTENSEURS DE BENZIMIDAZOLE À DOUBLE EFFET
ExternalDocumentID EP2162442A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP2162442A13
IEDL.DBID EVB
IngestDate Fri Jul 19 16:03:52 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP2162442A13
Notes Application Number: EP20080768064
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100317&DB=EPODOC&CC=EP&NR=2162442A1
ParticipantIDs epo_espacenet_EP2162442A1
PublicationCentury 2000
PublicationDate 20100317
PublicationDateYYYYMMDD 2010-03-17
PublicationDate_xml – month: 03
  year: 2010
  text: 20100317
  day: 17
PublicationDecade 2010
PublicationYear 2010
RelatedCompanies THERAVANCE, INC
RelatedCompanies_xml – name: THERAVANCE, INC
Score 2.767362
Snippet The invention is directed to compounds having the formula: wherein: Ar, r, n, X, R2-3 and R5-7 are as defined in the specification, and pharmaceutically...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title DUAL-ACTING BENZOIMIDAZOLE ANTIHYPERTENSIVE AGENTS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100317&DB=EPODOC&locale=&CC=EP&NR=2162442A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4QNOpNUSO-0oPprbFd7IMDMW13SzGwbaQQ5EL6TLgAkRr_vrO1oBe9bXazs4_sN4-dnVmAB43EIrxSV_S8SqptxUpidQslK_QCu2hGlorY4RE3_MnTy0yfNWC5i4Wp8oR-VskREVEp4r2s-PXm5xKLVm8rt4_JEqvWz17Uo3JtHWvijJoydXosDGjgyq6LJZm_IjANFGTERkPpALVoU4CBTR0RlLL5LVG8UzgMkdiqPINGvmrBsbv7eK0FR6Pa343FGnrbcyB0Yg8V8eaD9yWH8XmAbIfa82DIJJtHA_8tZKib8vFgihV9xqPxBUgei1xfwcEX-4UuWLifZucSmmj_51cgFZmVaqlVmCTpCGuvG2dqiooAyQy1IJbahvafZK7_abuBk29XuMhRegvN8v0jv0MJWyb31d58AaVrez0
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4QNOJNUSM-ezC9NbbFPjgQ08eWVtttI4UgF9JnwgWJ1Pj3na0Fvehts5udfWS_eezszALcSXLCwisVQSnqpNp6IqT6oBTyUimxi6TmGYsdDqjqTh6eZsqsBcttLEydJ_SzTo6IiMoQ71XNr9c_l1h2_bZyc58usert0YmHNt9YxxI7oxpvm0MShXZo8ZaFJZ6-IDBVFGSygYbSHmrYGgMDmZosKGX9W6I4R7AfIbFVdQytYtWFjrX9eK0LB0Hj78ZiA73NCcj2xPAF9uaDjjiT0HmIbMc25qFPOIPGnvsaEdRN6dibYsWI0Hh8CpxDYssVcPDFbqELEu2m2T-DNtr_xTlwZa5nUqaXmpz2mbU3SHIxQ0VAzlWxlHWxB70_yVz803YLHTcO_IXv0edLOPx2i7N8pVfQrt4_imuUtlV6U-_TF5hDfjA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DUAL-ACTING+BENZOIMIDAZOLE+ANTIHYPERTENSIVE+AGENTS&rft.inventor=HUDSON%2C+RYAN&rft.inventor=CHOI%2C+SEOK-KI&rft.inventor=GENDRON%2C+ROLAND&rft.inventor=MCMURTRIE%2C+DARREN&rft.inventor=FATHEREE%2C+PAUL%2C+R&rft.inventor=MCKINNELL%2C+ROBERT%2C+MURRAY&rft.inventor=JENDZA%2C+KEITH&rft.inventor=ALLEGRETTI%2C+PAUL&rft.inventor=OLSON%2C+BROOKE&rft.date=2010-03-17&rft.externalDBID=A1&rft.externalDocID=EP2162442A1